Primidone

Drug Usage Statistics, United States, 2005 - 2015

Number of Prescriptions Over Time (2005 - 2015)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 400 -
2005 358  42
2006 306  52
2007 292  14
2008 272  20
2009 321  49
Year Rank Change
2010 292  29
2011 314  22
2012 353  39
2014 340 -
2015 293  47

Patient Out-Of-Pocket Cost Over Time (2005 - 2015)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2015)
Gabapentin 43,320,666
Lamotrigine 12,096,328
Divalproex Sodium 6,112,173
Phenytoin 4,171,794
Oxcarbazepine 3,735,666
Primidone (this drug) 1,506,283

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Mysoline
Generic Drug Synonyms and Salts
  • Primidone

FDA Approval Information

Established Pharmacologic Class (EPC): Anti-epileptic Agent
Initial FDA approval date: Prior to January 1, 1982
First FDA applicant: Discn
First dosage form: Suspension (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2005-2015. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 18.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top
Top